Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety

US Patent 12403142 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for the targeted degradation of androgen receptor2025
Modulators of BCL6 proteolysis and associated methods of use2025
Modulators of estrogen receptor proteolysis and associated methods of use2025
Compounds and methods for the enhanced degradation of targeted proteins2025
Cereblon ligands and bifunctional compounds comprising the same2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025
SHP2 phosphatase allosteric inhibitor2025
Accelerating fibrosarcoma protein degrading compounds and associated methods of 2024
Compounds and methods for the targeted degradation of bromodomain- containing pr2024
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen recepto2024
Indazole based compounds and associated methods of use2024
Compounds and methods for the targeted degradation of rapidly accelerated fibros2024